Warning letterPosted May 27, 2025
FDA warning letter to DRG Instruments GmbH
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device
FDA posted a warning letter to DRG Instruments GmbH on May 27, 2025; the letter is dated March 31, 2025. Subject: Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device. Issuing office: Center for Devices and Radiological Health.
On the record
- Company
- DRG Instruments GmbH
- Subject
- Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device
- Issuing office
- Center for Devices and Radiological Health
- Letter dated
- 2025-03-31
- Posted by FDA
- 2025-05-27
- Source
- FDA warning letters ↗
CFR cited
The record cites 7 sections of 21 CFR Parts 803, 807, 820 and 862.
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch DRG Instruments GmbH
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with DRG Instruments GmbH.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.